S. Verma

发表

Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.

N. Gupta, S. Verma, Subodh Kumar, 2009, Vaccine.

Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications

Anil Kumar Singh, S. Shrivastava, S. Verma, 2013, Virus Genes.

Plague Vaccine Development: Current Research and Future Trends

S. Verma, U. Tuteja, 2016, Front. Immunol..

Characterization of Immune Responses to Yersinia pestis (Indian Isolate) Infection in Mouse Model

S. Verma, P. Pathak, U. Tuteja, 2013 .

Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.

S. Verma, U. Tuteja, Ankit Gupta, 2019, Vaccine.

Characterization of pandemic influenza A (H1N1) virus hemagglutinin specific polyclonal antibodies for biosensor applications

Anil Kumar Singh, B. Sikarwar, M. Boopathi, 2013, Journal of medical virology.

Protein Kinase N1 Is a Novel Substrate of NFATc1-mediated Cyclin D1-CDK6 Activity and Modulates Vascular Smooth Muscle Cell Division and Migration Leading to Inward Blood Vessel Wall Remodeling*

G. Rao, Sanjay Kumar, S. Verma, 2012, The Journal of Biological Chemistry.

Search for new prototypes for the chemotherapy of filariasis: a chemotherapeutic and biochemical approach

S. Verma, S. Misra-Bhattacharya, R. Tripathi, 2005, Parasitology Research.

Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100

T. Vogel, I. Astsaturov, D. Spaner, 2006, Cancer.

Japanese Encephalitis Outbreak, India, 2005

M. Parida, P. K. Dash, S. Verma, 2006, Emerging infectious diseases.

Peptides representing the specific variable regions but not the full porin proteins can be useful for antibody based diagnosis of typhoid fever

S. Verma, P. Ray, S. Kapil, 2010, Folia Microbiologica.

Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation

S. Verma, R. Kandasamy, Krubha Athirathinam, 2022, Vaccines.

Novel Role for p21-activated Kinase 2 in Thrombin-induced Monocyte Migration*

G. Rao, S. Verma, Sivareddy Kotla, 2013, The Journal of Biological Chemistry.

Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis

S. Verma, Subodh Kumar, Ankit Gupta, 2020, Frontiers in Immunology.

A Recombinant Trivalent Fusion Protein F1–LcrV–HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis

S. Verma, U. Tuteja, L. Batra, 2016, Front. Microbiol..

HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model

N. Saxena, S. C. Pant, S. Verma, 2014, PLoS neglected tropical diseases.

New-age vaccine adjuvants, their development, and future perspective

R. Rappuoli, A. Johri, S. Verma, 2023, Frontiers in Immunology.

East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India.

J. Babu, N. Gupta, M. Parida, 2007, Vector borne and zoonotic diseases.

Use of a Recombinant Burkholderia Intracellular Motility A Protein for Immunodiagnosis of Glanders

S. Verma, Subodh Kumar, V. Pal, 2011, Clinical and Vaccine Immunology.

Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice

S. Verma, Subodh Kumar, Shikha Jain, 2012, World Journal of Microbiology and Biotechnology.

Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice

S. Verma, Subodh Kumar, Shikha Jain, 2012, World Journal of Microbiology and Biotechnology.

Role of G-Proteins and GPCRs in Cardiovascular Pathologies

S. Verma, Geetika Kaur, D. Singh, 2023, Bioengineering.

Isolation and serological characterization of a Plasmodium vivax recombinant antigen

Y. D. Sharma, V. Sharma, S. Verma, 1991, Infection and immunity.

Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tail.

P. Cheng, S. Verma, A. Petrosyan, 2012, The international journal of biochemistry & cell biology.

IgG & IgM antibodies against measles virus in unvaccinated infants from Pune: evidence for subclinical infections.

S. Verma, K. Banerjee, S. R. Prasad, 1995, The Indian journal of medical research.

A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity

P. Shi, J. Gleeson, A. Terskikh, 2022, Cell reports.

Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.

J. Babu, Priyabrata Pattnaik, S. Verma, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model

A. Sette, E. Saphire, M. Kronenberg, 2023, Antiviral Research.

Protective antigen of Bacillus anthracis in combination with TLR4 or TLR5 agonist confers superior protection against lethal challenge in mouse model.

S. Verma, Subodh Kumar, Mahendra K. Gupta, 2023, Microbes and infection.

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination

S. Verma, Divyasha Saxena, L. Batra, 2023, Vaccines.

Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications

Anil Kumar Singh, S. Shrivastava, S. Verma, 2013, Virus Genes.

Recombinant YopE and LcrV vaccine candidates protect mice against plague and yersiniosis

A. Johri, S. Verma, S. Bhagyawant, 2024, Heliyon.